MA38292A1 - Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthrite - Google Patents
Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthriteInfo
- Publication number
- MA38292A1 MA38292A1 MA38292A MA38292A MA38292A1 MA 38292 A1 MA38292 A1 MA 38292A1 MA 38292 A MA38292 A MA 38292A MA 38292 A MA38292 A MA 38292A MA 38292 A1 MA38292 A1 MA 38292A1
- Authority
- MA
- Morocco
- Prior art keywords
- diclofenac
- composition
- salts
- pain associated
- prevent inflammation
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 4
- 229960001259 diclofenac Drugs 0.000 title abstract 4
- 150000003839 salts Chemical class 0.000 title abstract 3
- 206010061218 Inflammation Diseases 0.000 title 1
- 206010003246 arthritis Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 239000003889 eye drop Substances 0.000 abstract 1
- 229940012356 eye drops Drugs 0.000 abstract 1
- 238000007918 intramuscular administration Methods 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000006215 rectal suppository Substances 0.000 abstract 1
- 229940100618 rectal suppository Drugs 0.000 abstract 1
- 238000007920 subcutaneous administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La présente invention concerne une composition comprenant du diclofénac et des sels de celui-ci, le diclofénac ou ses sels étant présents dans une quantité de 25 à 200 mg. La composition est appropriée pour l'administration parentérale à travers une voie intraveineuse, intramusculaire ; également pour une administration orale, dermique, sous-cutanée, cutanée, nasale, par gouttes oculaires, comme suppositoire rectal, par pessaires vaginaux, intra-articulaire et otique. L'invention concerne également des compositions comprenant une combinaison de diclofénac et d'autres médicaments. L'invention concerne en outre un procédé de préparation de ladite composition.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3704MU2012 | 2012-12-28 | ||
| PCT/IN2013/000805 WO2014102824A1 (fr) | 2012-12-28 | 2013-12-27 | Composition de diclofénac |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA38292A1 true MA38292A1 (fr) | 2017-06-30 |
Family
ID=54198802
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA38292A MA38292A1 (fr) | 2012-12-28 | 2013-12-27 | Composition de diclofenac et ses sels, pour prevenir l'inflammation et la douleur associees au rhumatisme de l'arthrite |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US20140187635A1 (fr) |
| EP (1) | EP2938325B8 (fr) |
| JP (1) | JP6117939B2 (fr) |
| KR (1) | KR101730284B1 (fr) |
| CN (1) | CN104968331A (fr) |
| AP (1) | AP2015008534A0 (fr) |
| AU (1) | AU2013368849B2 (fr) |
| BR (1) | BR112015015699B1 (fr) |
| CL (1) | CL2015001869A1 (fr) |
| EA (1) | EA035079B1 (fr) |
| ES (1) | ES2721400T3 (fr) |
| HK (1) | HK1211858A1 (fr) |
| HU (1) | HUE045030T2 (fr) |
| IL (1) | IL239395A0 (fr) |
| MA (1) | MA38292A1 (fr) |
| MX (1) | MX365375B (fr) |
| MY (1) | MY184886A (fr) |
| PE (1) | PE20151208A1 (fr) |
| PH (1) | PH12015501479B1 (fr) |
| SG (1) | SG11201504577UA (fr) |
| SI (1) | SI2938325T1 (fr) |
| TR (1) | TR201905806T4 (fr) |
| UA (1) | UA114123C2 (fr) |
| WO (1) | WO2014102824A1 (fr) |
| ZA (1) | ZA201504258B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101524473B1 (ko) * | 2014-12-22 | 2015-06-02 | 주식회사 한국팜비오 | 주사제 조성물 |
| WO2016170401A1 (fr) * | 2015-04-20 | 2016-10-27 | Umedica Laboratories Pvt. Ltd | Nouvelle composition injectable de diclofénac sodique |
| US11110073B2 (en) | 2017-03-24 | 2021-09-07 | Cadila Healthcare Limited | Storage stable aqueous injectable solution comprising diclofenac |
| BR112020002804A2 (pt) | 2017-08-24 | 2020-07-28 | Novo Nordisk A/S | composição farmacêutica líquida, e, kit |
| GB201720992D0 (en) * | 2017-12-15 | 2018-01-31 | Hooper Mark | A medical use |
| GR1009729B (el) * | 2018-08-02 | 2020-05-15 | Win Medica Φαρμακευτικη Ανωνυμη Εταιρεια | Σταθερος ενεσιμος συνδυασμος |
| SG11202103374TA (en) * | 2018-11-16 | 2021-05-28 | Seikagaku Kogyo Co Ltd | Pharmaceutical composition |
| US20220280463A1 (en) | 2019-09-09 | 2022-09-08 | Ftf Pharma Private Limited | Pharmaceutical formulations comprising diclofenac |
| US11707443B2 (en) | 2019-09-26 | 2023-07-25 | Rk Pharma Inc. | Storage stable aqueous parenteral solutions comprising diclofenac |
| US12246024B2 (en) * | 2019-12-13 | 2025-03-11 | Free State Pharma Inc | Compositions and methods for controlling cerumen production |
| IL294521A (en) * | 2020-02-18 | 2022-09-01 | Novo Nordisk As | glp-1 compounds and their uses |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3324193A1 (de) | 1983-07-05 | 1985-01-17 | Troponwerke Gmbh & Co Kg | Depot-antiphlogistika |
| DE3446873A1 (de) | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
| US5283067A (en) * | 1987-01-30 | 1994-02-01 | Ciba-Geigy Corporation | Parenteral suspensions |
| AU662160B2 (en) * | 1991-07-04 | 1995-08-24 | Taisho Pharmaceutical Co., Ltd. | Analgesic |
| US5389681A (en) | 1992-10-22 | 1995-02-14 | Ciba-Geigy Corporation | Parenteral solutions for diclofenac salts |
| ZA949182B (en) | 1993-12-02 | 1995-07-26 | South African Druggists Ltd | Pharmaceutical composition |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Ｋｄｌ株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| US20050203000A1 (en) * | 2003-03-26 | 2005-09-15 | Sutter Diane E. | Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection |
| WO2005027977A2 (fr) * | 2003-09-22 | 2005-03-31 | Agis Industries (1983) Ltd. | Compositions de diclofenac destinees au traitement d'affections cutanees |
| DE602004025151D1 (de) | 2004-03-10 | 2010-03-04 | Shimoda Biotech Pty Ltd | Stabile injizierbare Diclofenac- Zubereitungen |
| US20050214230A1 (en) * | 2004-03-23 | 2005-09-29 | J. B. Chemicals & Pharmaceuticals Ltd. | Novel stomatological gel |
| EA013616B1 (ru) * | 2005-02-01 | 2010-06-30 | Троикаа Фармасьютикалз Лтд. | Инъекционные препараты диклофенака и его фармацевтически приемлемых солей |
| BRPI0611170A2 (pt) * | 2005-05-27 | 2010-08-17 | Panacea Biotec Ltd | composições injetáveis e processo para o preparo de tais composições |
| BRPI0921654A2 (pt) | 2008-11-28 | 2016-02-10 | Advance Holdings Ltd | formulação farmacêutica |
-
2013
- 2013-12-24 US US14/140,109 patent/US20140187635A1/en not_active Abandoned
- 2013-12-27 UA UAA201506371A patent/UA114123C2/uk unknown
- 2013-12-27 ES ES13830158T patent/ES2721400T3/es active Active
- 2013-12-27 EA EA201591230A patent/EA035079B1/ru not_active IP Right Cessation
- 2013-12-27 MA MA38292A patent/MA38292A1/fr unknown
- 2013-12-27 HU HUE13830158A patent/HUE045030T2/hu unknown
- 2013-12-27 MX MX2015008369A patent/MX365375B/es active IP Right Grant
- 2013-12-27 BR BR112015015699-1A patent/BR112015015699B1/pt active IP Right Grant
- 2013-12-27 WO PCT/IN2013/000805 patent/WO2014102824A1/fr not_active Ceased
- 2013-12-27 HK HK15112837.5A patent/HK1211858A1/xx unknown
- 2013-12-27 SI SI201331424T patent/SI2938325T1/sl unknown
- 2013-12-27 JP JP2015550212A patent/JP6117939B2/ja active Active
- 2013-12-27 EP EP13830158.5A patent/EP2938325B8/fr active Active
- 2013-12-27 TR TR2019/05806T patent/TR201905806T4/tr unknown
- 2013-12-27 SG SG11201504577UA patent/SG11201504577UA/en unknown
- 2013-12-27 PE PE2015001194A patent/PE20151208A1/es not_active Application Discontinuation
- 2013-12-27 CN CN201380068194.2A patent/CN104968331A/zh active Pending
- 2013-12-27 KR KR1020157017781A patent/KR101730284B1/ko not_active Expired - Fee Related
- 2013-12-27 MY MYPI2015001527A patent/MY184886A/en unknown
- 2013-12-27 AP AP2015008534A patent/AP2015008534A0/xx unknown
- 2013-12-27 AU AU2013368849A patent/AU2013368849B2/en not_active Ceased
-
2015
- 2015-06-11 ZA ZA2015/04258A patent/ZA201504258B/en unknown
- 2015-06-14 IL IL239395A patent/IL239395A0/en unknown
- 2015-06-26 CL CL2015001869A patent/CL2015001869A1/es unknown
- 2015-06-26 PH PH12015501479A patent/PH12015501479B1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR201905806T4 (tr) | Diklofenak bileşimi. | |
| BR112013027667A2 (pt) | limitador para um dispositivo de dispensação | |
| EA201200519A1 (ru) | Стабилизированные жидкие и лиофилизированные композиции adamts13 | |
| MA45598B1 (fr) | Stéroles 24-hydroxylés substitués en position 11 pour le traitement des maladies liées au récepteur nmda | |
| MA35753B1 (fr) | Aryl-dihydropyridinones et pipéridinones en tant qu'inhibiteurs de mgat2 | |
| MA45504B1 (fr) | Utilisation d'inhibiteurs de télomérase pour le traitement de troubles myéloprolifératifs et de néoplasies myéloprolifératives | |
| MA33909B1 (fr) | Pyrrolidinones accoles en tant d'inhibiteurs de syk | |
| FI3593814T3 (fi) | Vasta-aineformulaatio | |
| MA30291B1 (fr) | Derives de l'azolopyridin-3-one en tant qu'inhibiteurs de la lipase endotheliale | |
| AU2019268085A1 (en) | Compound of glycosaminoglycan, preparation method and use thereof | |
| MA32056B1 (fr) | Suspension pharmaceutique orale contenant du paracetamol et de l'ibuprofene | |
| TN2015000547A1 (fr) | Composes heteroaromatiques et leur utilisation comme ligands de dopamine d1 | |
| AR078304A1 (es) | Agonistas receptores de oxitocina | |
| MA33533B1 (fr) | Compositions pharmaceutiques pour le traitement du cancer et d'autres maladies ou troubles | |
| MA35281B1 (fr) | Dosage et administration d'anticorps anti-erbb3 en combinaison avec le paclitaxel pour le traitement de cancers gynécologiques | |
| MA34489B1 (fr) | Agonistes du récepteur a1 à l'adénosine destinés au traitement du glaucome et de l'hypertension oculaire | |
| MA35305B1 (fr) | Nouveaux acides pipéridinylmonocarboxyliques à titre d'agonistes des récepteurs de s1p1 | |
| BR112015021425A2 (pt) | composições lubrificantes que incluem copolímeros de alfa-olefina | |
| BR112012024585A2 (pt) | inibidores de pkc para o tratamento de linfomade células b tendo sinalização do receptor de células b ativas crônicas | |
| IN2012DN01251A (fr) | ||
| NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
| TN2015000176A1 (fr) | Pastille medicamenteuse a base d'ibuprofene sodique dihydrate | |
| MA53898B1 (fr) | Dérivés de 4-pyrazin-2-ylméthyl-morpholine et leur utilisation comme médicament | |
| BR112012011231A2 (pt) | novo tratamento da inflamação sistêmica de baixo grau | |
| FR2983398B1 (fr) | Canule et adaptateur pour seringue multifonction |